Showing results (2521-2530 of 2,674) with videos related to

Sort By:
Pageof 268
Nutrients|November 8, 2019
5-(Hydroxyphenyl)-γ-Valerolactone-Sulfate, a Key Microbial Metabolite of Flavan-3-ols, Is Able to Reach the Brain: Evidence from Different in Silico, In Vitro and In Vivo Experimental ModelsDonato Angelino, Diogo Carregosa, Cristina Domenech-Coca, et al.
The Lancet. Oncology|December 15, 2023
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 studyAristotelis Bamias, Ian D Davis, Matthew D Galsky, et al.
JAMA Dermatology|December 27, 2019
Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical TrialMargitta Worm, Eric L Simpson, Diamant Thaçi, et al.
Nature Communications|November 3, 2020
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoidsJing Zhao, Yuan Fu, Yu Yamazaki, et al.
Translational Andrology and Urology|May 10, 2021
Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancerEdmond M Kwan, Heidi Fettke, Megan Crumbaker, et al.
The Lancet. Oncology|October 1, 2020
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trialAndrew Kneebone, Carol Fraser-Browne, Gillian M Duchesne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trialA M Scott, F T Lee, W Hopkins, et al.
European Urology Focus|July 30, 2017
Development of Indicators to Assess Quality of Care for Prostate CancerNupur Nag, Jeremy Millar, Ian D Davis, et al.
American Journal of Human Genetics|December 25, 2012
Exome sequencing identifies mutations in CCDC114 as a cause of primary ciliary dyskinesiaMichael R Knowles, Margaret W Leigh, Lawrence E Ostrowski, et al.
European Urology Oncology|February 22, 2026
WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on DarolutamideBarak Talmor, Carole A Harris, Christopher Gianacas, et al.
Pageof 268